Medical Devices & Equipment Company
3%
Aegis has developed a surgically implanted device that reduces the risk of stroke in patients suffering from irregular heartbeat by preventing the flow of blood between the heart and left atrial appendage on the left side of the heart.
Sign up now to unlock full company profiles and access financials, investor documents, and engage companies.
Development based on IP Licensed from 3 Cardiologists at Mayo Clinic. Worked in close partnership with a leading American academic medical clinic and Biomerics LLC partners to develop a (patent protected) engineered device that can deliver a simpler, cheaper and safer percutaneous epicardial procedure for left atrial appendage (LAA) closure. The “Sierra” is one of the only “single access” epicardial (LAA) closure devices and procedures known to be in development; • Patented electrocardiogram (ECG) navigation for less invasive and more accurate closure• Patented hollow structure ligation• One size fits all economics• Repositionable design• Elimination of Heparin or post procedure oral anticoagulation (OAC)Features: 1. Single access, no need to enter circulation or manage two access points. 2. Shortest implant times 3. Safety, no device left in LAA 4. Efficacy: Reduce stroke, hypertension & potential - reductions in BP. Better closure rates of LAA to prevent clots.
EXECUTIVE CHAIR, Bcomm., J.D., Q.C. • Venture Capitalist, Lawyer• Performed a variety of instrumental roles in the formation, development and/or operation of over 11 public companies, 8 of these were sold for proceeds in excess of $1.6 billion. The largest of those remaining, Pan American Silver Corp, has a market Capitalization of $12 billion• Juris Doctorate from the University of British Columbia• Graduate degree in commerce from Dalhousie University• Appointed Queen's Counsel, in 2012
PRESIDENT & CHIEF EXECUTIVE OFFICER, MBA• Former Director, President & CEO of Tree Island Steel Ltd.• Former Chair, Prince Rupert Port Authority. Greenfield build of new container terminal, commissioned in 2007 • 40+ Years of business experience• Honours Graduate in Business, Seneca College• MBA , University of Western Ontario
World's Top Physician, M.D., Ph.D.• Professor of Medicine - Jagiellonian University, Department of Cardiovascular and Transplant Surgery. Ph.D. in medical sciences• Surgeon – Cardiothoracic, specializing in Surgical and hybrid management of subjects with atrial fibrillation and has regularly been engaged for clinical trials• Depth of experience in developement of new techniques and devices for interventional cardiology and cardiac surgery• Performed first Aegis trial and will perform subsequent trials• Investigator, Co-Investigator and Clinical study coordinator in more than 100 Clinical Trials. Most FDA controlled• Primary investigator and Co investigator in 30 first in man clinical studies (as of 2022)• Author and co-author of 177 publications including publications in Lancet, European Journal of Cardio-Thoracic Surgery, Annals of Thoracic Surgery, Acta Cardiologica, Cell Tissue Banking, Heart Surgery Forum, America
CHIEF FINANCIAL OFFICER, CPA, CA, ACA., LLB Hons• Chartered Professional Accountant (CPA, CA) with over 25 years experience including public practice • Member of the Chartered Professional Accountants of British Columbia and The Institute of Chartered Accountants in England and Wales• Extensive experience in financial reporting and internal controls compliance for public companies• Extensive experience leading and coordinating corporate acquisitions and dispositions • CPA, CA Designation (Canada)• Chartered Accountant (ACA) Qualification in UK• Law with French (LLB Hons), University of Birmingham
VICE PRESIDENT, REGULATORY COMPLIANCE AND CORPORATE SECRETARY• More than 25 years of public company experience including corporate affairs, legal and regulatory administration, securities compliance, and governance.• Paralegal Diploma from Capilano University
GENERAL COUNSEL, LLB• Experienced corporate lawyer and entrepreneur with a demonstrated history of providing legal services in the high tech, insurance, mining and entertainment industries.•Skilled in advising early-stage businesses on matters ranging from going-public transactions, licensing and asset purchases, regulatory and securities compliance, to investor relations and internal management and employment issues.•Law and undergraduate degrees from University of British Columbia.
EXECUTIVE CHAIR, Ageis Medical Innovation, Bcomm., J.D., Q.C. • Venture Capitalist, Lawyer• Performed a variety of instrumental roles in the formation, development and/or operation of over 11 public companies, 8 of these were sold for proceeds in excess of $1.6 billion. The largest of those remaining, Pan American Silver Corp, has a market Capitalization of $12 billion• Juris Doctorate from the University of British Columbia• Graduate degree in commerce from Dalhousie University• Appointed Queen's Counsel, in 2012
Vancouver, BC V7M 2J5, Canada
Users who follow these tips increase their fundraising odds substantially.
No commitment. Start in minutes.
Already a member? Log In